ARCA biopharma (ABIO)

Add to Watchlists
Create an Alert
1.30 +0.00  +0.00% NASDAQ Oct 20, 16:59 Delayed 2m USD

ARCA biopharma Total Liabilities (Quarterly):

2.549M for June 30, 2017
View 4,000+ financial data types
Browse...
View Full Chart

ARCA biopharma Total Liabilities (Quarterly) Chart

Export Data
Save Image
Print Image

ARCA biopharma Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
June 30, 2017 2.549M
March 31, 2017 2.553M
Dec. 31, 2016 2.435M
Sept. 30, 2016 2.199M
June 30, 2016 1.744M
March 31, 2016 2.344M
Dec. 31, 2015 1.504M
Sept. 30, 2015 1.304M
June 30, 2015 1.357M
March 31, 2015 1.134M
Dec. 31, 2014 1.391M
Sept. 30, 2014 0.841M
June 30, 2014 1.219M
March 31, 2014 1.121M
Dec. 31, 2013 1.503M
Sept. 30, 2013 0.769M
June 30, 2013 0.75M
March 31, 2013 0.828M
Dec. 31, 2012 0.305M
Sept. 30, 2012 0.286M
June 30, 2012 0.529M
March 31, 2012 0.602M
Dec. 31, 2011 0.77M
Sept. 30, 2011 0.686M
June 30, 2011 1.036M
   
March 31, 2011 1.701M
Dec. 31, 2010 1.385M
Sept. 30, 2010 1.031M
June 30, 2010 1.233M
March 31, 2010 1.367M
Dec. 31, 2009 1.96M
Sept. 30, 2009 5.155M
June 30, 2009 22.56M
March 31, 2009 26.43M
Dec. 31, 2008 49.26M
Sept. 30, 2008 30.68M
June 30, 2008 34.67M
March 31, 2008 52.06M
Dec. 31, 2007 53.02M
Sept. 30, 2007 57.98M
June 30, 2007 65.97M
March 31, 2007 102.02M
Dec. 31, 2006 114.56M
Sept. 30, 2006 92.75M
June 30, 2006 90.89M
March 31, 2006 94.24M
Dec. 31, 2005 51.28M
Sept. 30, 2005 48.51M
June 30, 2005 40.68M
March 31, 2005 34.26M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Advertisement

ABIO Total Liabilities (Quarterly) Benchmarks

Companies
TearLab 33.65M
Celldex Therapeutics 114.61M
Achieve Life Sciences 1.775M

ABIO Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 0.305M Dec 2012
Maximum 2.553M Mar 2017
Average 1.466M

ABIO Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("ABIO", "liabilities")
  • Last 5 data points: =YCS("ABIO", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.